Watchung

Skye Bioscience Appoints Head of Regulatory Affairs & Quality Assurance and Senior Director of Research & Development

Retrieved on: 
Thursday, October 7, 2021

SAN DIEGO, CA, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (Skye), a biopharmaceutical company developing proprietary cannabinoid-derived molecules to treat diseases with significant unmet need, has strengthened its management team with the appointment of Rhea Williams, MPH, as Head of Regulatory Affairs & Quality Assurance and Varun Khurana, PhD, as Senior Director of Research & Development.

Key Points: 
  • SAN DIEGO, CA, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (Skye), a biopharmaceutical company developing proprietary cannabinoid-derived molecules to treat diseases with significant unmet need, has strengthened its management team with the appointment of Rhea Williams, MPH, as Head of Regulatory Affairs & Quality Assurance and Varun Khurana, PhD, as Senior Director of Research & Development.
  • Rhea Williams, MPH, brings over 25 years of experience in drug development, regulatory affairs and quality assurance.
  • Dr. Varun Khurana brings over seven years of comprehensive experience in pre-formulation and formulation development, technical transfer, CMC, CMO/CRO management and regulatory submissions for innovative and complex drug development programs.
  • We expect their proven track records and deep expertise to make an immediate impact on our development efforts.

Skye Bioscience Appoints Head of Regulatory Affairs & Quality Assurance and Senior Director of Research & Development

Retrieved on: 
Thursday, October 7, 2021

SAN DIEGO, CA, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (Skye), a biopharmaceutical company developing proprietary cannabinoid-derived molecules to treat diseases with significant unmet need, has strengthened its management team with the appointment of Rhea Williams, MPH, as Head of Regulatory Affairs & Quality Assurance and Varun Khurana, PhD, as Senior Director of Research & Development.

Key Points: 
  • SAN DIEGO, CA, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (Skye), a biopharmaceutical company developing proprietary cannabinoid-derived molecules to treat diseases with significant unmet need, has strengthened its management team with the appointment of Rhea Williams, MPH, as Head of Regulatory Affairs & Quality Assurance and Varun Khurana, PhD, as Senior Director of Research & Development.
  • Rhea Williams, MPH, brings over 25 years of experience in drug development, regulatory affairs and quality assurance.
  • Dr. Varun Khurana brings over seven years of comprehensive experience in pre-formulation and formulation development, technical transfer, CMC, CMO/CRO management and regulatory submissions for innovative and complex drug development programs.
  • We expect their proven track records and deep expertise to make an immediate impact on our development efforts.

Bayberry Elementary School Watchung Playground Opening

Retrieved on: 
Tuesday, June 4, 2019

On Tuesday June 4, at 2:00 p.m., a ribbon-cutting ceremony will be held for a new playground for the Bayberry Elementary School in Watchung.

Key Points: 
  • On Tuesday June 4, at 2:00 p.m., a ribbon-cutting ceremony will be held for a new playground for the Bayberry Elementary School in Watchung.
  • The ceremony, hosted by Mayor Keith Balla, Superintendent Stephanie Bilenker, and School Principal Jill Dobrowansky, will unveil a transformed playground.
  • The new playground was made possible by the generosity of the Watchung Education Foundation and the Bisignano Family in collaboration with the Nancy Lieberman Charities organization.
  • The opening ceremony for the playground will be held at the Bayberry Elementary School, 113 Bayberry Lane, Watchung, New Jersey, and feature speakers from the Watchung Board of Education, joined by Bill Ard, Super Bowl Champion, Bayberry School graduate and long term Watchung resident; Nancy Lieberman, Basketball Hall of Famer and two-time Olympian; Tracy Bisignano and Frank Bisignano, Chairman and CEO of First Data, and Watchung resident.

Temporary Restraining Order Entered Against The Manhattan Club

Retrieved on: 
Monday, August 20, 2018

Disclosure of the owner list will enable owners to organize to redress the Sponsor's wrongful conduct.

Key Points: 
  • Disclosure of the owner list will enable owners to organize to redress the Sponsor's wrongful conduct.
  • Unfortunately, the AOD left most TMC owners without remedy or compensation, and has yet to provide benefit to any owners.
  • Zimmerman Law Group has decades of experience successively litigating sophisticated commercial cases, obtaining millions of dollars in awards and settlements.
  • For further information, please contact: Jean-Marc Zimmerman, Zimmerman Law Group, 233 Watchung Fork, Westfield, NJ 07090, [email protected] .